Do NSAIDs Take Us Away From Treatment Goals in Axial Spondyloarthritis: A Story About Dysbiosis or Just a Matter of Bias?

Non-steroidal anti-inflammatory drugs (NSAIDs) remain the mainstay of treatment for spondyloarthritides (SpA), a group of entities with common clinical and pathophysiological aspects, but also with differential features. Although NSAIDs provide significant symptomatic relief, especially for joint pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Queiro-Silva, Rubén, García-Valle, Andrea, Alonso-Castro, Sara, Alperi-López, Mercedes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739512/
https://www.ncbi.nlm.nih.gov/pubmed/35004794
http://dx.doi.org/10.3389/fmed.2021.817884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739512/
https://www.ncbi.nlm.nih.gov/pubmed/35004794
http://dx.doi.org/10.3389/fmed.2021.817884

Ejemplares similares